03 July 2020
Visiongain has launched a new pharma report Clinical Workflow Solutions Market Report 2020-2030: Forecasts by Type (Care Collaboration Solutions (Medication Administration Solutions, Perinatal Care Management Solutions, Rounding Solutions, Other Care Collaboration Solutions), Enterprise Reporting & Analytics Solutions, Data Integration Solutions (EMR Integration Solutions, Medical Image Integration Solutions), Real-Time Communication Solutions (Nurse Call Alert Systems, Unified Communication Solutions), Workflow Automation Solutions (Nursing & Staff Scheduling Solutions, Patient Flow Management Solutions)), End User (Hospitals, Long-term Care Facilities, Ambulatory Care Centers), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global clinical workflow solutions market is anticipated to grow at a lucrative CAGR of ~xyz% and anticipated to reach USD xyz billion by 2020 owing to growing demand to curtail healthcare costs and the increasing patient volume.
To access the data contained in this document please email firstname.lastname@example.org
Clinical workflow solutions apply to software technologies that help boost patient trust by merging imaging silos, streamlining workflows, and facilitating collaboration. Also, these workflow solutions help to monitor workflow through analytics and surveillance reporting.
Hospitals and medical settings are in the process of integrating time-consuming documentation workflows, management of medical and administrative personnel, as well as easy access to clinical and administrative patient data across departments. Multimodal hospitals need to exchange data with their regional offices, thereby through the usage of standard interoperable solutions. Growing demand for caregivers for increased health quality and patient-centered provision of treatment increases the need for such programs. Several entities, including the public and private sectors, have recognized the importance of the clinical workflow management system. Additionally, clinical settings are initiatives across the globe are promoting the installation & integration of EHR & support systems for clinical decision making. This is anticipated to have a positive impact on the adoption of clinical workflow solutions.
The global clinical workflow solutions market growth is attributed to rapid adoption coupled with technological advancements that allow easy adaptability & reduced complexity. Furthermore, the introduction of cloud-based software to upgrade clinical information management systems is expected to fuel overall industry growth. These systems make it easier to store and retrieve the data. Also, the effective integration of interoperability in the healthcare sector has fueled the market growth.
In the year 2019, North America dominated the global clinical workflow solutions market owing to the growing volume of research & development activities, & patient admission in the hospitals leading to a high volume of data entry. Also, the market will continue to be driven by rising healthcare spending on digitization for the secure exchange of data within organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing demand for healthcare information technology solutions across emerging economies of India and China. Additionally, unmet needs of patients, supportive government initiatives for the implementation of eHealth, improving healthcare infrastructure, rising medical tourism, and untapped nations in this region have been attracting investments by global players and this is expected to boost the clinical workflow solutions market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the clinical workflow solutions market.
The comprehensive market report features companies such as Allscripts Healthcare Solutions, Inc., Ascom Holding AG, Athenahealth, Inc., Cerner Corporation, Cisco Systems, Inc., GE Healthcare, Hill-Rom Holdings, Inc., Infor, Inc., Koninklijke Philips N.V., Mckesson Corporation, NXGN Management, LLC, Stanley Black & Decker, Inc., Company13, Company14, Company15, Company16, Company17, Company18, Company19, Company20 among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.